322 related articles for article (PubMed ID: 38129938)
21. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
Bais MV
J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
[TBL] [Abstract][Full Text] [Related]
22. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA FAM239A promotes tumor cell proliferation and migration by regulating tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 in head and neck squamous cell carcinoma.
Li Y; Guo Y; Liu Z; Mou Y; Fang H; Yang Y; Zhao X; Zhang H; Song X
Arch Oral Biol; 2023 Mar; 147():105615. PubMed ID: 36630765
[TBL] [Abstract][Full Text] [Related]
24. The Two Faces of Immune-Related lncRNAs in Head and Neck Squamous Cell Carcinoma.
Bueno-Urquiza LJ; Martínez-Barajas MG; Villegas-Mercado CE; García-Bernal JR; Pereira-Suárez AL; Aguilar-Medina M; Bermúdez M
Cells; 2023 Feb; 12(5):. PubMed ID: 36899863
[TBL] [Abstract][Full Text] [Related]
25. Mouse Models for Head and Neck Squamous Cell Carcinoma.
Zhou J; Liu C; Amornphimoltham P; Cheong SC; Gutkind JS; Chen Q; Wang Z
J Dent Res; 2024 Jun; 103(6):585-595. PubMed ID: 38722077
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
Chen X; Liu Y; Sun D; Sun R; Wang X; Li M; Song N; Ying J; Guo T; Jiang Y
Cancer Sci; 2022 Jun; 113(6):2071-2084. PubMed ID: 35403343
[TBL] [Abstract][Full Text] [Related]
27. Fifteen mRNA-lncRNA expression-based signature predicted the survival of late-staged head and neck squamous cell carcinoma.
Ren H; Li H; Li P; Xu Y; Liu G; Sun L
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32500914
[TBL] [Abstract][Full Text] [Related]
28. Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis.
Wang S; Chen X; Qiao T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846802
[TBL] [Abstract][Full Text] [Related]
29. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
[TBL] [Abstract][Full Text] [Related]
30. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
31. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
[TBL] [Abstract][Full Text] [Related]
32. Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.
Metheetrairut C; Chotigavanich C; Amornpichetkul K; Keskool P; Ongard S; Metheetrairut C
Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):521-533. PubMed ID: 30515607
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis.
Wu J; Chen H; Li J; Li X; Cao J; Qi M
Bioengineered; 2021 Dec; 12(1):5607-5619. PubMed ID: 34515611
[TBL] [Abstract][Full Text] [Related]
34. Identification and in vitro validation of prognostic lncRNA signature in head and neck squamous cell carcinoma.
Wang J; Bian Q; Liu J; Moming A
Bioengineered; 2021 Dec; 12(2):10049-10062. PubMed ID: 34872450
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of lncRNA BLACAT1 enhances radiosensitivity of head and neck squamous cell carcinoma cells by regulating PSEN1.
Gou C; Han P; Li J; Gao L; Ji X; Dong F; Su Q; Zhang Y; Liu X
Br J Radiol; 2020 Apr; 93(1108):20190154. PubMed ID: 31944856
[TBL] [Abstract][Full Text] [Related]
36. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation.
Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H
J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157
[TBL] [Abstract][Full Text] [Related]
37. Risk SNP-mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
Hou Y; Zhou M; Li Y; Tian T; Sun X; Chen M; Xu W; Lu M
Mol Carcinog; 2022 Aug; 61(8):797-811. PubMed ID: 35687049
[TBL] [Abstract][Full Text] [Related]
38. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
[TBL] [Abstract][Full Text] [Related]
39. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
40. Multiomics Integrative Analysis Identifying
Dai Y; Chen W; Huang J; Zheng L; Lin Q; Cui T; Huang C
Biomed Res Int; 2022; 2022():1074412. PubMed ID: 36158885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]